Today I am grateful for and appreciate the untiring efforts of EHN Canada to facilitate webinars regarding mental health for promoting awareness. Today's webinar titled "Pharmacology of Alcohol Use Disorder (AUD)" hosted by Jeremy Houston and presented by Dr. Tim Ayas, MD, FRCPC, CCFP, MPH, BSc psychiatrist at EHN Sandstone. I acknowledge and recognize the significance of today's webinar for a variety of reasons, for instance:
- This webinar was over the zoom, highly convenient to join at this time of the COVID 19 pandemic while professional gatherings are prohibited. No need to formally dress up, drive or take TTC. It was just one click away
- Today's webinar was incredible and germinated my insight to the next level as far as AUD is concerned. This was a great way to take further advancement and growth in the field of mental health
- The taken insight and words from webinar is:
- Definition of alcohol use disorder by DSM V was discussed
- Epidemiology of Alcohol Use Disorder (AUD)
- Epidemiology of concurrent disorders
- Genetics of Alcohol Use Disorder (AUD) - dehydrogenase enzyme
- COVID - 19 and Alcohol Use Disorder (AUD)
- Fact: Drinking methanol, ethanol or bleach DOES NOT prevent or cure COVID 19 infection
- Public Health Measures
- Psychotherapy options including 12 steep. CBT, MI, couples and family therapy, DBT and interpersonal therapy
- Pharmacotherapy options: approved, off label, medication dosage, side effects and clinical tips were discussed
- Pharmacology flow chart for the treatment of Alcohol Use Disorder (AUD) was discussed in detail
- Detoxification process
- The alternate medication also an option
- Inpatient Residential Treatment Centres
- There was a Q A session
- This is my journey with EHN Canada's webinar series, find webinars that take your professional development to the next level, is the thought of the day
If you have any question or concern, please feel free to ask or comment below
No comments:
Post a Comment